Australia was indeed the "lucky country" in the recent worldwide SARS epidemic [5]

Medical Journal of Australia

Volumn 181, Issue 4, 2004, Pages 229-230

  Jauncey, Marianne E ^a   Armstrong, Paul K ^a   Morgan, Emily L ^b   McAnulty, Jeremy M ^a  

^a New South Wales Government   (Australia)

^b Ballina West Medical Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; AUSTRALIA; CASE REPORT; DISEASE TRANSMISSION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION CONTROL; LETTER; PATIENT CARE; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; TOURISM;

EID: 4444320113     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06249.x     Document Type: Letter

References (5)

1. Radun D, Niedrig M, Ammon A, Stark K. SARS: retrospective cohort study among German guests of the Hotel 'M', Hong Kong. Euro Surveill 2003; 8: 228-230.
2. Consensus document of the epidemiology of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. Available at: www.who.int/csr/sars/en/WHOconsensus.pdf (accessed Mar 2003).
3. Chan P, Ng K, Chan R, et al. Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis 2004; 10: 530-532.
4. Darby P. The economic impact of SARS. The Conference Board of Canada: Special Briefing, May 2003. Available at: www.dfait-maeci.gc.ca/mexico-city/economic/may/sarsbriefMay03.pdf (accessed Mar 2003).
5. Pang X, Zhu Z, Xu F, et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA 2003; 290: 3215-3221.